RICHMOND, Calif., Sept. 20, 2017 /PRNewswire/
-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced
today that Sandy Macrae, M.B.,
Ch.B., Ph.D., Sangamo's chief executive officer, will present at
the 2017 Cantor Fitzgerald Global Healthcare Conference on
Wednesday, September 27th
at 10:55 a.m. Eastern Time. The
conference is being held in New
York from September 25-27,
2017.
The presentation will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investors and Media
section under Events and Presentations. The presentation will be
archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the Company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit www.sangamo.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-2017-cantor-fitzgerald-global-healthcare-conference-300523025.html
SOURCE Sangamo Therapeutics, Inc.